Literature DB >> 26123803

Evolution of the Immune Response to Chronic Airway Colonization with Aspergillus fumigatus Hyphae.

Mirjam Urb1, Brendan D Snarr1, Gabriella Wojewodka2, Mélanie Lehoux1, Mark J Lee1, Benjamin Ralph1, Maziar Divangahi3, Irah L King1, Toby K McGovern4, James G Martin4, Richard Fraser5, Danuta Radzioch2, Donald C Sheppard6.   

Abstract

Airway colonization by the mold Aspergillus fumigatus is common in patients with underlying lung disease and is associated with chronic airway inflammation. Studies probing the inflammatory response to colonization with A. fumigatus hyphae have been hampered by the lack of a model of chronic colonization in immunocompetent mice. By infecting mice intratracheally with conidia embedded in agar beads (Af beads), we have established an in vivo model to study the natural history of airway colonization with live A. fumigatus hyphae. Histopathological examination and galactomannan assay of lung homogenates demonstrated that hyphae exited beads and persisted in the lungs of mice up to 28 days postinfection without invasive disease. Fungal lesions within the airways were surrounded by a robust neutrophilic inflammatory reaction and peribronchial infiltration of lymphocytes. Whole-lung cytokine analysis from Af bead-infected mice revealed an increase in proinflammatory cytokines and chemokines early in infection. Evidence of a Th2 type response was observed only early in the course of colonization, including increased levels of interleukin-4 (IL-4), elevated IgE levels in serum, and a mild increase in airway responsiveness. Pulmonary T cell subset analysis during infection mirrored these results with an initial transient increase in IL-4-producing CD4(+) T cells, followed by a rise in IL-17 and Foxp3(+) cells by day 14. These results provide the first report of the evolution of the immune response to A. fumigatus hyphal colonization.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26123803      PMCID: PMC4534667          DOI: 10.1128/IAI.00359-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Serum immunoglobulins E and G anti-Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis.

Authors:  A P Knutsen; P S Hutcheson; K R Mueller; R G Slavin
Journal:  J Lab Clin Med       Date:  1990-11

2.  Pulmonary eosinophilia with and without allergic bronchopulmonary aspergillosis.

Authors:  B J Chapman; S Capewell; R Gibson; A P Greening; G K Crompton
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

3.  Immunopathologic responses to Aspergillus antigen in interleukin-4 knockout mice.

Authors:  V P Kurup; J Guo; P S Murali; H Choi; J N Fink
Journal:  J Lab Clin Med       Date:  1997-12

4.  Aspergillus fumigatus AcuM regulates both iron acquisition and gluconeogenesis.

Authors:  Hong Liu; Fabrice N Gravelat; Lisa Y Chiang; Dan Chen; Ghyslaine Vanier; Daniele E Ejzykowicz; Ashraf S Ibrahim; William C Nierman; Donald C Sheppard; Scott G Filler
Journal:  Mol Microbiol       Date:  2010-09-27       Impact factor: 3.501

5.  Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma.

Authors:  Nandini Krishnamoorthy; Anupriya Khare; Timothy B Oriss; Mahesh Raundhal; Christina Morse; Manohar Yarlagadda; Sally E Wenzel; Martin L Moore; R Stokes Peebles; Anuradha Ray; Prabir Ray
Journal:  Nat Med       Date:  2012-09-09       Impact factor: 53.440

6.  Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation.

Authors:  D R Hospenthal; K J Kwon-Chung; J E Bennett
Journal:  Med Mycol       Date:  1998-06       Impact factor: 4.076

7.  Aspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils.

Authors:  Patricia R Taylor; Sixto M Leal; Yan Sun; Eric Pearlman
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

8.  The Th17 pathway in cystic fibrosis lung disease.

Authors:  Hui-Leng Tan; Nicolas Regamey; Sarah Brown; Andrew Bush; Clare M Lloyd; Jane C Davies
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

9.  Galactosaminogalactan, a new immunosuppressive polysaccharide of Aspergillus fumigatus.

Authors:  Thierry Fontaine; Aurélie Delangle; Catherine Simenel; Bernadette Coddeville; Sandra J van Vliet; Yvette van Kooyk; Silvia Bozza; Silvia Moretti; Flavio Schwarz; Coline Trichot; Markus Aebi; Muriel Delepierre; Carole Elbim; Luigina Romani; Jean-Paul Latgé
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

10.  Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display.

Authors:  Tobias M Hohl; Heather L Van Epps; Amariliz Rivera; Laura A Morgan; Patrick L Chen; Marta Feldmesser; Eric G Pamer
Journal:  PLoS Pathog       Date:  2005-11-18       Impact factor: 6.823

View more
  15 in total

Review 1.  Beyond tissue concentrations: antifungal penetration at the site of infection.

Authors:  Yanan Zhao; Brendan Prideaux; Shane Baistrocchi; Donald C Sheppard; David S Perlin
Journal:  Med Mycol       Date:  2019-04-01       Impact factor: 4.076

2.  A Murine Model for Chronic A. fumigatus Airway Infections.

Authors:  Benjamin Ralph; Donald C Sheppard
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Airway Microbiota and the Implications of Dysbiosis in Asthma.

Authors:  Juliana Durack; Homer A Boushey; Susan V Lynch
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 4.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 5.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

6.  Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases as Antibiofilm Agents in Acute Pulmonary Pseudomonas aeruginosa Infection.

Authors:  Hanna Ostapska; Deepa Raju; Rachel Corsini; Melanie Lehoux; Ira Lacdao; Stephanie Gilbert; Piyanka Sivarajah; Natalie C Bamford; Perrin Baker; Fabrice N Gravelat; P Lynne Howell; Donald C Sheppard
Journal:  Antimicrob Agents Chemother       Date:  2022-07-07       Impact factor: 5.938

7.  Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in Patients with HIV and Pneumonia.

Authors:  Meera K Shenoy; Shoko Iwai; Din L Lin; William Worodria; Irene Ayakaka; Patrick Byanyima; Sylvia Kaswabuli; Serena Fong; Stephen Stone; Emily Chang; J Lucian Davis; Ali Ahmad Faruqi; Mark R Segal; Laurence Huang; Susan V Lynch
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

Review 8.  Aspergillosis and stem cell transplantation: An overview of experimental pathogenesis studies.

Authors:  Nadia Al-Bader; Donald C Sheppard
Journal:  Virulence       Date:  2016-09-29       Impact factor: 5.882

9.  Co-Operative Biofilm Interactions between Aspergillus fumigatus and Pseudomonas aeruginosa through Secreted Galactosaminogalactan Exopolysaccharide.

Authors:  Hanna Ostapska; François Le Mauff; Fabrice N Gravelat; Brendan D Snarr; Natalie C Bamford; Jaime C Van Loon; Geoffrey McKay; Dao Nguyen; P Lynne Howell; Donald C Sheppard
Journal:  J Fungi (Basel)       Date:  2022-03-24

Review 10.  Dendritic cells in lung immunopathology.

Authors:  Peter C Cook; Andrew S MacDonald
Journal:  Semin Immunopathol       Date:  2016-06-02       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.